Search the catalog

Toxicology|Endocrine|In Vitro Alternate

OECD 455: Estrogen receptor transcriptional activation (ERTA)

Record Type:Study

Estrogen Receptor (ER) Transcriptional Activation Testing (OECD 455/OPPTS 890.1300) is used for Level 2 testing of substances with potential to be endocrine disruptors. It evaluates the substance’s estrogen agonist activity mediated by human ER-alpha (hERα) in a human cell line modified to incorporate a firefly luciferase gene (HeLa-9903). If a substance binds to hERα, it enters the nucleus and transactivates the luciferase gene. Increased transcriptional activity of the gene is determined by lysing the cells and running an assay which measures bioluminescence produced by the action of luciferase on its substrate, luciferin. Concentration–response relationships are reported, with RPCMax, PCMax, PC50 and/or PC10 and EC50 values.

Industry Market

Crop,Chemical,Pharma

Phase

Nonclinical

Related Capabilities

Request Information
file
file
file

About our nonclinical animal research models: We provide the utmost care for our research animals and actively pursue advances in animal welfare. As well as ensuring the highest scientific, ethical and regulatory standards, selection of appropriate animal research models for development research is critical to developing safe and effective treatments, devices and products that protect and save lives. Just as we have ethical committee oversight for human trials, we have ethical committees overseeing all aspects of our global animal care and use programs. All of our core, nonclinical facilities are accredited by AAALAC.Learn more about our commitment to replacing, reusing and refining nonclinical research models.